LGND Ligand Pharmaceuticals Incorporated
Healthcare$229.33+3.22%ClosedMarket Cap: $4.60B
As of 2026-05-25
Insider Statistics (Q2 2026)
Acquisitions
4
Dispositions
29
Buy/Sell Ratio
0.14
Net Shares
-12,968
Shares Acquired
12,034
Shares Disposed
25,002
Total Bought ($)
$0.00
Total Sold ($)
$25.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Thu May 14 | KOZARICH JOHN W | director | Sell | 1,575 | $223.50 | 41,786 |
| Thu May 14 | KOZARICH JOHN W | director | Sell | 459 | $224.00 | 41,786 |
| Thu May 14 | KOZARICH JOHN W | director | Sell | 165 | $231.87 | 42,007 |
| Thu May 14 | KOZARICH JOHN W | director | Sell | 116 | $234.09 | 41,786 |
| Thu May 14 | KOZARICH JOHN W | director | Sell | 105 | $232.57 | 41,902 |
| Thu May 14 | KOZARICH JOHN W | director | Sell | 80 | $227.37 | 42,173 |
| Thu May 14 | KOZARICH JOHN W | director | Sell | 1 | $229.87 | 42,172 |
| Thu May 14 | KOZARICH JOHN W | director | Sell | 1,575 | $69.51 | 43,361 |
| Thu May 14 | KOZARICH JOHN W | director | Sell | 459 | $69.51 | 42,245 |
| Mon May 04 | Reardon Andrew | officer: CLO & Secretary | Sell | 1,420 | $232.92 | 42,182 |
| Mon May 04 | Reardon Andrew | officer: CLO & Secretary | Sell | 932 | $228.75 | 44,850 |
| Mon May 04 | Reardon Andrew | officer: CLO & Secretary | Sell | 800 | $234.02 | 41,382 |
| Mon May 04 | Reardon Andrew | officer: CLO & Secretary | Sell | 780 | $232.04 | 43,602 |
| Mon May 04 | Reardon Andrew | officer: CLO & Secretary | Sell | 600 | $227.45 | 45,782 |
| Mon May 04 | Reardon Andrew | officer: CLO & Secretary | Sell | 370 | $230.87 | 44,382 |